
NYSEHealthcareMedical - Healthcare Information Services
أحدث البيانات المتاحة
10.81 US$
+0.15 US$ · +1.41%
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
الإغلاق السابق
10.81 US$
+0.15 US$ · +1.41%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
نطاق اليوم
السعر الحالي 10.81 US$
نطاق 52 أسبوعًا
السعر الحالي 10.81 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
62
أقل من القيمة
المشاعر
60
مختلط
المخاطر
64
مخاطر مرتفعة
الزخم
32
زخم متراجع
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
نطاق اليوم
السعر الحالي 10.81 US$
نطاق 52 أسبوعًا
السعر الحالي 10.81 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2026 | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 |
|---|---|---|---|---|---|
| الإيرادات | 480.59 مليون USD | 419.81 مليون USD | 356.3 مليون USD | 280.91 مليون USD | 213.23 مليون USD |
| تكلفة البضاعة المباعة | 154.12 مليون USD | 134.93 مليون USD | 124.01 مليون USD | 109.27 مليون USD | 81.39 مليون USD |
| الربح الإجمالي | 326.47 مليون USD | 284.88 مليون USD | 232.29 مليون USD | 171.64 مليون USD | 131.85 مليون USD |
| البحث والتطوير | 121.48 مليون USD | 117.36 مليون USD | 112.35 مليون USD | 91.24 مليون USD | 52.27 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 180.15 مليون USD | 197.73 مليون USD | 226.93 مليون USD | 231.65 مليون USD | 175.1 مليون USD |
| نفقات التشغيل | 333.08 مليون USD | 342.98 مليون USD | 368.77 مليون USD | 348.2 مليون USD | 248.66 مليون USD |
| دخل الفوائد | 2.17 مليون USD | 2.68 مليون USD | 4.07 مليون USD | 2.48 مليون USD | 79 ألف USD |
| مصاريف الفوائد | 6.95 مليون USD | 2.35 مليون USD | 1.85 مليون USD | 1.41 مليون USD | 1.16 مليون USD |
| الاستهلاك والإطفاء | 31.45 مليون USD | 27.89 مليون USD | 29.49 مليون USD | 25.3 مليون USD | 24.52 مليون USD |
| الدخل التشغيلي | −6.61 مليون USD | −58.1 مليون USD | −136.48 مليون USD | −176.55 مليون USD | −116.82 مليون USD |
| صافي الدخل | 2.31 مليون USD | −58.53 مليون USD | −136.89 مليون USD | −176.15 مليون USD | −118.16 مليون USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
12.00 US$
ارتفاع محتمل بنسبة 11.01%صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI22.43 مليون0.00%2.3 ترليون USD0.03%381.94 US$+0.63%
iShares Russell 2000 ETFIWM14.4 مليون0.02%78.74 مليار USD0.19%278.94 US$+0.49%
Vanguard Extended Market ETFVXF8.23 مليون0.01%95.4 مليار USD0.05%235 US$+0.80%
Fidelity Enhanced Small Cap ETFFESM5.48 مليون0.08%6.41 مليار USD0.28%45.46 US$+0.46%
iShares Russell 2000 Growth ETFIWO4.24 مليون0.03%13.92 مليار USD0.24%356.78 US$+0.94%
Vanguard Russell 2000 ETFVTWO3.49 مليون0.02%18 مليار USD0.06%112.66 US$+0.50%
Schwab U.S. Small-Cap ETFSCHA2.79 مليون0.01%21.82 مليار USD0.03%32.79 US$+0.40%
Principal U.S. Small-Cap Multi-Factor ETFPSC2.45 مليون0.09%2.7 مليار USD0.38%67.70 US$+0.61%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Fidelity Enhanced Small Cap ETFFESM
iShares Russell 2000 Growth ETFIWO
Vanguard Russell 2000 ETFVTWO
Schwab U.S. Small-Cap ETFSCHA
Principal U.S. Small-Cap Multi-Factor ETFPSCالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.